Evidence map›Paper›PMID 35164292›Full record

ArticleMolecules (Basel, Switzerland)2022

Nanoparticles of

Duaa Bakhshwin, Khadija Abdul Jalil Faddladdeen, Soad Shaker Ali, Samar Mohammed Alsaggaf, Nasra Naeim Ayuob

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Duaa BakhshwinDepartment of Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
Khadija Abdul Jalil FaddladdeenBiology Department, Faculty of Science, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
Soad Shaker AliDepartment of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
Samar Mohammed AlsaggafDepartment of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi Arabia.
Nasra Naeim AyuobDepartment of Medical Histology and Cell Biology, Faculty of Medicine, Damietta University, Damietta 34511, Egypt.
King Abdulaziz University · SADamietta University · EG

Funding

Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia 694-248-1441
6 · The paper itself

Abstract

Diabetes mellitus is a common global health problem. Among the complications that are frequently associated with DM are the alternation of sexual function and fertility, especially in young men. This study aimed to assess the efficacy of nanoparticles of

Indexed as

CostusAnimalsAnti-Inflammatory AgentsDiabetes Mellitus, ExperimentalDown-RegulationHypoglycemic AgentsInterleukin-1betaInterleukin-6MaleMetal NanoparticlesProstateRatsTumor Necrosis Factor-alphaAnti-Inflammatory AgentsHypoglycemic AgentsIL1B protein, ratInterleukin-1betaInterleukin-6Tumor Necrosis Factor-alphaBcl-2Costus speciosuscytokinesdiabetes mellitusinflammationinsulinKi67nanoparticlesprostatetestosterone

Identifiers

PMID35164292
PMCPMC8839105
OpenAlexW4210750784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.